These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 26803615)

  • 1. A cluster-analytical approach toward real-world outcome in outpatients with stable schizophrenia.
    Rocca P; Montemagni C; Mingrone C; Crivelli B; Sigaudo M; Bogetto F
    Eur Psychiatry; 2016 Feb; 32():48-54. PubMed ID: 26803615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Empirically driven definitions of "good," "moderate," and "poor" levels of functioning in the treatment of schizophrenia.
    Ascher-Svanum H; Novick D; Haro JM; Aguado J; Cui Z
    Qual Life Res; 2013 Oct; 22(8):2085-94. PubMed ID: 23239123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining "good" and "poor" outcomes in patients with schizophrenia or schizoaffective disorder: a multidimensional data-driven approach.
    Lipkovich IA; Deberdt W; Csernansky JG; Buckley P; Peuskens J; Kollack-Walker S; Rotelli M; Houston JP
    Psychiatry Res; 2009 Dec; 170(2-3):161-7. PubMed ID: 19897252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Competitive employment in schizophrenia: clinical and neuropsychological correlates and quality of life].
    Birindelli N; Castagna F; Giugiario M; Graffino M; Mingrone C; Sandei L; Rocca P
    Riv Psichiatr; 2012; 47(2):89-95. PubMed ID: 22622245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative contribution of antipsychotics, negative symptoms and executive functions to social functioning in stable schizophrenia.
    Rocca P; Montemagni C; Castagna F; Giugiario M; Scalese M; Bogetto F
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):373-9. PubMed ID: 19211031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of physician and patient rated quality of life during antipsychotic treatment in outpatients with schizophrenia.
    Wehmeier PM; Kluge M; Schacht A; Helsberg K; Schreiber W; Schimmelmann BG; Lambert M
    J Psychiatr Res; 2008 Jul; 42(8):676-83. PubMed ID: 17720192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should we consider mood disturbance in schizophrenia as an important determinant of quality of life?
    Tollefson GD; Andersen SW
    J Clin Psychiatry; 1999; 60 Suppl 5():23-9; discussion 30. PubMed ID: 10192404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attitudes of schizophrenia outpatients toward psychiatric medications: relationship to clinical variables and insight.
    Freudenreich O; Cather C; Evins AE; Henderson DC; Goff DC
    J Clin Psychiatry; 2004 Oct; 65(10):1372-6. PubMed ID: 15491241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained favorable long-term outcome in the treatment of schizophrenia: a 3-year prospective observational study.
    Cuyún Carter GB; Milton DR; Ascher-Svanum H; Faries DE
    BMC Psychiatry; 2011 Aug; 11():143. PubMed ID: 21871092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life and subjective well-being during treatment with antipsychotics in out-patients with schizophrenia.
    Wehmeier PM; Kluge M; Schneider E; Schacht A; Wagner T; Schreiber W
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):703-12. PubMed ID: 17289237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abbreviated quality of life scales for schizophrenia: comparison and utility of two brief community functioning measures.
    Fervaha G; Foussias G; Siddiqui I; Agid O; Remington G
    Schizophr Res; 2014 Apr; 154(1-3):89-92. PubMed ID: 24630140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Negative symptoms and everyday functioning in schizophrenia: a cross-sectional study in a real world-setting.
    Rocca P; Montemagni C; Zappia S; Piterà R; Sigaudo M; Bogetto F
    Psychiatry Res; 2014 Aug; 218(3):284-9. PubMed ID: 24814140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life in stable schizophrenia: the relative contributions of disorganization and cognitive dysfunction.
    Sigaudo M; Crivelli B; Castagna F; Giugiario M; Mingrone C; Montemagni C; Rocca G; Rocca P
    Schizophr Res; 2014 Mar; 153(1-3):196-203. PubMed ID: 24485197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study.
    Bobes J; Arango C; Garcia-Garcia M; Rejas J;
    J Clin Psychiatry; 2010 Mar; 71(3):280-6. PubMed ID: 19895779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment resistant schizophrenia is associated with the worst community functioning among severely-ill highly-disabling psychiatric conditions and is the most relevant predictor of poorer achievements in functional milestones.
    Iasevoli F; Giordano S; Balletta R; Latte G; Formato MV; Prinzivalli E; De Berardis D; Tomasetti C; de Bartolomeis A
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Feb; 65():34-48. PubMed ID: 26320028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of subjective and objective quality of life in outpatients with schizophrenia.
    Yamauchi K; Aki H; Tomotake M; Iga J; Numata S; Motoki I; Izaki Y; Tayoshi S; Kinouchi S; Sumitani S; Tayoshi S; Takikawa Y; Kaneda Y; Taniguchi T; Ishimoto Y; Ueno S; Ohmori T
    Psychiatry Clin Neurosci; 2008 Aug; 62(4):404-11. PubMed ID: 18778437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive function and competitive employment in schizophrenia: relative contribution of insight and psychopathology.
    Giugiario M; Crivelli B; Mingrone C; Montemagni C; Scalese M; Sigaudo M; Rocca G; Rocca P
    Soc Psychiatry Psychiatr Epidemiol; 2012 Apr; 47(4):553-61. PubMed ID: 21451974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Functional outcome in schizophrenia: a comparative cross-sectional study on first versus second generation antipsychotics].
    Montemagni C; Birindelli N; Castagna F; Mingrone C; Sigaudo M; Zappia S; Rocca P
    Riv Psichiatr; 2009; 44(2):110-6. PubMed ID: 20066812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Quality of life in patients with schizophrenia: a study of 100 cases].
    Zouari L; Thabet JB; Elloumi Z; Elleuch M; Zouari N; Maâlej M
    Encephale; 2012 Apr; 38(2):111-7. PubMed ID: 22516268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of symptomatology and cognitive deficits to functional capacity in schizophrenia.
    Perlick DA; Rosenheck RA; Kaczynski R; Bingham S; Collins J
    Schizophr Res; 2008 Feb; 99(1-3):192-9. PubMed ID: 17851042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.